Pantherna Therapeutics

Description: Pantherna Therapeutics develops first-in-class mRNA-based therapeutics for vascular diseases using advanced nanoparticle delivery tech.

Country: Germany

Based in: Hennigsdorf

Founded: 2017

Funding Stage: Pre-Seed

Tags: ['Biotechnology', 'Health Care', 'Pharmaceutical', 'Therapeutics']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.